BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Ultragenyx Pharmaceutical Inc. (RARE) investor events
X-WR-CALNAME:Ultragenyx Pharmaceutical Inc. (RARE) investor events
DESCRIPTION:Earnings calls and investor events for Ultragenyx Pharmaceutica
 l Inc. (RARE)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Ultragenyx Pharmaceutic
 al Inc. (RARE)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:c0d06450-45d2-48bc-b9ca-48259881d354@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20251202T201500Z
DTEND:20251202T211500Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Citi’s 2025 Glo
 bal Healthcare Conference
DESCRIPTION:Citi’s 2025 Global Healthcare Conference\nWebcast: https://kv
 go.com/global-healthcare-conference-2025/ultragenyx-december-2025
END:VEVENT
BEGIN:VEVENT
UID:f09b62cf-f959-4479-8bbd-7153eb4d1c10@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20251203T175500Z
DTEND:20251203T185500Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: 8th Annual Everco
 re ISI Healthcare Conference
DESCRIPTION:8th Annual Evercore ISI Healthcare Conference\nWebcast: https:/
 /wsw.com/webcast/evercore52/rare/2355540
END:VEVENT
BEGIN:VEVENT
UID:a1d7d9af-e20e-492f-af01-1da0191ecaaa@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20260112T183000Z
DTEND:20260112T193000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: 44th Annual J.P. 
 Morgan Healthcare Conference
DESCRIPTION:44th Annual J.P. Morgan Healthcare Conference\nWebcast: https:/
 /jpmorgan.metameetings.net/events/healthcare26/sessions/317251-ultragenyx-
 pharmaceutical/webcast?gpu_only=true&kiosk=true
END:VEVENT
BEGIN:VEVENT
UID:73051923-33ea-495a-be95-69e94331d122@equibles.com
DTSTAMP:20260611T143152Z
DTSTART;VALUE=DATE:20260212
DTEND;VALUE=DATE:20260213
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://event.
 choruscall.com/mediaframe/webcast.html?webcastid=3R5yLizy
URL:https://equibles.com/stocks/rare/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:88faf43d-9fc4-4c6c-838c-abb5633871bd@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20260302T185000Z
DTEND:20260302T195000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: 46th Annual Cowen
  Healthcare Conference
DESCRIPTION:46th Annual Cowen Healthcare Conference\nWebcast: https://event
 .summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/K5FQGufP4rPEMQVwMWvdmM
END:VEVENT
BEGIN:VEVENT
UID:a067bc4f-4e25-4fbe-b0fb-408a6f503851@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20260310T160000Z
DTEND:20260310T170000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Barclays 28th Ann
 ual Global Healthcare Conference
DESCRIPTION:Barclays 28th Annual Global Healthcare Conference\nWebcast: htt
 ps://cc.webcasts.com/barc002/031026a_js/?entity=3_HFLJ3N2
URL:https://equibles.com/stocks/rare/events/a067bc4f-4e25-4fbe-b0fb-408a6f5
 03851
END:VEVENT
BEGIN:VEVENT
UID:b3b79b5c-a475-46d3-8be6-1413fa0be3c6@equibles.com
DTSTAMP:20260701T231023Z
DTSTART:20260311T140000Z
DTEND:20260311T150000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Leerink Partners 
 Global Biopharma Conference-
DESCRIPTION:Leerink Partners Global Biopharma Conference-\nWebcast: https:/
 /event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/78ivuSY5oynVa6dc3n8hR2
END:VEVENT
BEGIN:VEVENT
UID:53bd00b8-340d-4888-8681-a0c76297ccd4@equibles.com
DTSTAMP:20260611T154158Z
DTSTART;VALUE=DATE:20260505
DTEND;VALUE=DATE:20260506
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://event.
 choruscall.com/mediaframe/webcast.html?webcastid=p8c3kTVK
URL:https://equibles.com/stocks/rare/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:00b04c2b-9cb5-472b-8051-7644cace1ba8@equibles.com
DTSTAMP:20261024T145322Z
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260513
SEQUENCE:25628002
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Bank of America 2
 026 Healthcare Conference
DESCRIPTION:Bank of America 2026 Healthcare Conference\nThe start time has 
 not been announced.\nWebcast: https://bofa.veracast.com/webcasts/bofa/heal
 thcare2026/2As0d9.cfm
URL:https://equibles.com/stocks/rare/events/00b04c2b-9cb5-472b-8051-7644cac
 e1ba8
END:VEVENT
BEGIN:VEVENT
UID:1d2f03b4-9461-474b-b34f-15a440898583@equibles.com
DTSTAMP:20260624T233113Z
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260610
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Goldman Sachs 47t
 h Annual Global Healthcare Conference
DESCRIPTION:Goldman Sachs 47th Annual Global Healthcare Conference\nThe sta
 rt time has not been announced.\nWebcast: https://ir.ultragenyx.com/events
 /event-details/goldman-sachs-47th-annual-global-healthcare-conference
URL:https://equibles.com/stocks/rare/events/1d2f03b4-9461-474b-b34f-15a4408
 98583
END:VEVENT
BEGIN:VEVENT
UID:61246ee2-cb65-4d72-8797-68a1e90236a8@equibles.com
DTSTAMP:20260805T100834Z
DTSTART;VALUE=DATE:20260804
DTEND;VALUE=DATE:20260805
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://ir.ult
 ragenyx.com/events-presentations
URL:https://equibles.com/stocks/rare/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:1185051c-299a-479d-bab4-17780f231fc6@equibles.com
DTSTAMP:20260820T235847Z
DTSTART:20260819T220000Z
DTEND:20260819T230000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Ultragenyx Corpor
 ate Update Conference Call
DESCRIPTION:Ultragenyx Corporate Update Conference Call\nWebcast: https://e
 vent.choruscall.com/mediaframe/webcast.html?webcastid=CY3cnBkt
URL:https://equibles.com/stocks/rare/events/1185051c-299a-479d-bab4-17780f2
 31fc6
END:VEVENT
BEGIN:VEVENT
UID:a13b552b-47ff-4b4b-ac57-05dd645f5be3@equibles.com
DTSTAMP:20260922T095243Z
DTSTART:20260917T213000Z
DTEND:20260917T223000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Conference: Ultragenyx Confer
 ence Call
DESCRIPTION:Ultragenyx Conference Call\nWebcast: https://event.choruscall.c
 om/mediaframe/webcast.html?webcastid=1t78iDYA
URL:https://equibles.com/stocks/rare/events/a13b552b-47ff-4b4b-ac57-05dd645
 f5be3
END:VEVENT
BEGIN:VEVENT
UID:6eb5e586-f5f4-46cc-9d6d-abe42ff89c98@equibles.com
DTSTAMP:20261028T032051Z
DTSTART:20261103T220000Z
DTEND:20261103T230000Z
SEQUENCE:25932051
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Ultragenyx Pharmaceutical Inc. (RARE) Earnings Call\, FY2026 Q3
DESCRIPTION:Webcast: https://event.choruscall.com/mediaframe/webcast.html?w
 ebcastid=gHPjc0BE
URL:https://equibles.com/stocks/rare/calls/2026-q3
END:VEVENT
END:VCALENDAR
